News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
276,768 Results
Type
Article (14678)
Company Profile (285)
Press Release (261805)
Section
Business (82306)
Career Advice (211)
Deals (13790)
Drug Delivery (37)
Drug Development (50998)
Employer Resources (44)
FDA (5933)
Job Trends (5395)
News (148727)
Policy (10391)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (985)
Accelerated approval (2)
Adcomms (12)
Allergies (50)
Alliances (22486)
ALS (62)
Alzheimer's disease (843)
Antibody-drug conjugate (ADC) (90)
Approvals (5951)
Artificial intelligence (119)
Autoimmune disease (13)
Automation (6)
Bankruptcy (111)
Best Places to Work (4774)
BIOSECURE Act (6)
Biosimilars (42)
Biotechnology (234)
Bladder cancer (45)
Brain cancer (20)
Breast cancer (146)
Cancer (1343)
Cardiovascular disease (119)
Career advice (184)
Career pathing (7)
CAR-T (109)
Cell therapy (313)
Cervical cancer (8)
Clinical research (41373)
Collaboration (519)
Compensation (231)
Complete response letters (14)
COVID-19 (1058)
CRISPR (37)
C-suite (148)
Cystic fibrosis (76)
Data (1407)
Denatured (11)
Depression (29)
Diabetes (127)
Diagnostics (1413)
Digital health (4)
Diversity (2)
Diversity, equity & inclusion (17)
Drug discovery (82)
Drug pricing (29)
Drug shortages (3)
Duchenne muscular dystrophy (83)
Earnings (30658)
Editorial (18)
Employer branding (5)
Employer resources (43)
Events (49718)
Executive appointments (419)
FDA (6579)
Featured Employer (32)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (491)
Gene editing (89)
Generative AI (9)
Gene therapy (234)
GLP-1 (364)
Government (1134)
Grass and pollen (2)
Guidances (18)
Healthcare (6972)
Huntington's disease (21)
IgA nephropathy (21)
Immunology and inflammation (80)
Indications (18)
Infectious disease (1121)
Inflammatory bowel disease (113)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (58)
Interviews (25)
IPO (7525)
IRA (12)
Job creations (919)
Job search strategy (167)
Kidney cancer (6)
Labor market (4)
Layoffs (209)
Leadership (6)
Legal (1434)
Liver cancer (31)
Lung cancer (191)
Lymphoma (89)
Machine learning (2)
Management (11)
Manufacturing (124)
MASH (49)
Medical device (2817)
Medtech (2818)
Mergers & acquisitions (6568)
Metabolic disorders (371)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (61)
Neuropsychiatric disorders (23)
Neuroscience (1221)
NextGen: Class of 2025 (2159)
Non-profit (1004)
Northern California (1611)
Now hiring (24)
Obesity (190)
Opinion (109)
Ovarian cancer (61)
Pain (41)
Pancreatic cancer (52)
Parkinson's disease (111)
Partnered (8)
Patents (114)
Patient recruitment (69)
Peanut (35)
People (26260)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14588)
Phase II (19209)
Phase III (12193)
Pipeline (754)
Podcasts (48)
Policy (41)
Postmarket research (894)
Preclinical (6115)
Press Release (30)
Prostate cancer (55)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (283)
Real estate (1534)
Recruiting (18)
Regulatory (8854)
Reports (15)
Research institute (1006)
Resumes & cover letters (21)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (56)
Series A (97)
Series B (61)
Service/supplier (1)
Sickle cell disease (40)
Southern California (1400)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (2041)
State (1)
Stomach cancer (4)
Supply chain (19)
Tariffs (3)
The Weekly (36)
United States (12609)
Vaccines (214)
Venture capitalists (28)
Webinars (7)
Weight loss (105)
Women's health (15)
Worklife (3)
Date
Today (68)
Last 7 days (450)
Last 30 days (1663)
Last 365 days (20519)
2025 (5065)
2024 (21140)
2023 (23030)
2022 (27636)
2021 (28590)
2020 (24141)
2019 (17124)
2018 (12364)
2017 (14191)
2016 (12285)
2015 (14835)
2014 (10755)
2013 (7887)
2012 (7960)
2011 (8051)
2010 (7763)
Location
Africa (162)
Alabama (38)
Alaska (3)
Arizona (65)
Arkansas (5)
Asia (18004)
Australia (3006)
California (3634)
Canada (1112)
China (332)
Colorado (146)
Connecticut (149)
Delaware (88)
Europe (38136)
Florida (442)
Georgia (112)
Idaho (16)
Illinois (227)
India (11)
Indiana (89)
Iowa (1)
Japan (74)
Kansas (59)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (453)
Massachusetts (2853)
Michigan (70)
Minnesota (140)
Mississippi (1)
Missouri (28)
Montana (16)
Nebraska (4)
Nevada (16)
New Hampshire (15)
New Jersey (930)
New Mexico (12)
New York (992)
North Carolina (572)
North Dakota (4)
Northern California (1611)
Ohio (110)
Oklahoma (9)
Oregon (21)
Pennsylvania (712)
Puerto Rico (3)
Rhode Island (17)
South America (223)
South Carolina (4)
Southern California (1400)
Tennessee (28)
Texas (423)
Utah (48)
Virginia (72)
Washington D.C. (28)
Washington State (327)
Wisconsin (15)
276,768 Results for "bridge therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Jaguar Health Announces Closing of Bridge Financing Priced At-The-Market Under Nasdaq Rules
April 2, 2025
·
5 min read
Press Releases
Irazú Oncology Secures Bridge Funding, Expands Leadership Team and Facilities
March 5, 2025
·
2 min read
Opinion
How mRNA Can Help Bridge the Innovation Gap in Rare Disease
As it did during the COVID-19 pandemic, mRNA technology offers an efficient way forward in developing products for diseases that lack approved treatments.
February 28, 2025
·
3 min read
·
Kyle Holen
Management
Stuck in the Middle: How Millennial Managers Can Bridge Generational Gaps
Getting caught between younger team members and older bosses can be stressful for millennial managers. A leadership expert and millennial manager share tips for bridging the gap between these groups.
September 4, 2024
·
4 min read
·
Angela Gabriel
Press Releases
Adial Pharmaceuticals Receives Positive Response from FDA Meeting Regarding Proposed In Vitro Bridging Strategy for AD04
February 26, 2025
·
6 min read
Press Releases
Bridge Biotherapeutics and HitGen Initiate Research Collaboration to Advance Novel Cancer Therapeutics Program
August 22, 2024
·
4 min read
Biotech Bay
GPCR Therapeutics Announces Out-Licensing Agreement with Bridge Biotherapeutics in Idiopathic Pulmonary Fibrosis
GPCR Therapeutics, Inc., a clinical-stage international biopharmaceutical company, announces it enters into an out-licensing agreement with Bridge Biotherapeutics for the CXCR4-LPA1 inhibitor combination method of treatment.
December 14, 2023
·
4 min read
Pharm Country
SFA Therapeutics Announces Updated Psoriasis Data for SFA-002, Bridge Financing, and Foundational Patent
SFA Therapeutics is pleased to announce the completion of a bridge financing of $4.5 million, led by North South Ventures.
November 9, 2023
·
4 min read
Drug Development
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China
On June 25, China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) announced the completion of dosing for the first subject in the phase III bridging trial of ruxolitinib cream (the “Product”) in atopic dermatitis (“AD”) in China.
June 25, 2024
·
8 min read
Genetown
Arch Therapeutics Completes Financing as Bridge to Uplisting
Arch Therapeutics, Inc. announced that it completed a private placement with institutional and accredited individual investors as a Bridge Offering preceding a planned national exchange listing of the Company’s common stock on either Nasdaq Global Market, Nasdaq Capital Market, New York Stock Exchange or NYSE American.
September 7, 2023
·
5 min read
1 of 27,677
Next
